Patient Care

Vision testing results from 384 public transport drivers in Mumbai found the Visiolite 4K screener accurately matched standard assessments while cutting screening time by 65%.

Jem Martin, OD, discusses the accommodations and referrals any provider can offer, the red flags that should raise suspicion of CVI, and how the free TEACHCVI screening tool works in practice.

Heru's PretestPro runs 4 pretesting exams in about 90 seconds on the Heru Prime wearable platform and reaches all current and future customers via free software update.

Merabet, OD, PhD, MPH, discusses what his research on motion processing reveals about the neural roots of CVI and where diagnostic tools like neuroimaging and eye tracking are headed.

Catch up on the top stories in optometry during the week of August 31-September 4.

Cerebral visual impairment is now the leading cause of childhood vision loss. Three experts explain the history, science, and clinical signs eye care providers need to know.

Catch up on the top stories in optometry during the week of August 10-14.

A recent study examined the current state of readability in ophthalmic letters addressed to patients following their appointment and provides recommended solutions for improvement.

Elkins shares the moving realities of volunteering with Remote Area Medical, from patients lining up before dawn to what it takes for an OD to get involved.

Physicians recommend a Mediterranean or similar diet to slow the progression of age-related macular degeneration, the leading cause of irreversible vision loss in older adults.

Through at home delivery, and in-office dispense in permitted states, Orasis Pharmaceuticals and BlinkRx aim to improve accessibility of Qlosi eye drops for presbyopia treatment.

A 10-year analysis finds latanoprost accounts for 40% of glaucoma prescriptions in New Zealand.

Jessica Steen, OD, FAAO, DipABO, stated that each ADC can have distinct ophthalmic monitoring needs and management protocols.

Mila Ioussifova, OD, CNS, FAAO, FOWNS, details her session on the hormonal and aesthetic considerations ODs should make when treating these patients.

Jessica Steen, OD, FAAO, DipABO, weighs in on what the optometric community should know concerning what side effects their patients may experience.

Jacqueline Theis, OD, FAAO, underscored the importance of individualizing care based on where the patient is in their MS journey.

Mohammad Rafieetary, OD, FAAO, FORS, DipABO, ABCMO, discussed his AOA 2026 presentation "Eye of the Needle Returns: Navigating the Patient’s Journey Receiving Intravitreal Injections."

A cross-sectional study of nearly 10,000 nursing home residents found a clear dose-response relationship between vision loss and cognitive impairment, with blind residents having nearly 3 times the odds of cognitive loss compared with those with normal vision.

A systematic review of 22 studies found Demodex infestation strongly associated with MGD, with MGD prevalence reaching 92% to 99% in symptomatic Demodex blepharitis and significantly worse meibomian gland structure and function in infested patients.

A VA case report documents rapid PDR progression to intravitreal anti-VEGF treatment in a patient 6 months after semaglutide initiation, reinforcing AOA monitoring guidance for GLP-1 patients with preexisting DR.

Daniel C. Brocks, MD, BostonSight chief medical officer, discusses a few of the company's studies, the patients they serve, and what the broader eye care community may be missing.

Kevin J. Kovach, MD, and Giannie Castellanos, OD, gave their insights this season on what helps build referral trust and long-lasting comanagement relationships.

Samuel Berchuck, PhD, discussed his poster on sequential screening for psychological distress in glaucoma clinics using AI-assisted methods.

Jessilin Quint, OD, MBA, MS, FAAO, shares strategies for improving adherence, building trust through patient communication, and more.

Explore why near work—not just screens—drives kids’ myopia risk, while silent dry eye worsens early; learn practical habits to boost prevention and compliance.